Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47,898,935
-
Total 13F shares
-
50,973,144
-
Share change
-
-268,264
-
Total reported value
-
$1,478,067,581
-
Price per share
-
$28.99
-
Number of holders
-
169
-
Value change
-
-$32,032,171
-
Number of buys
-
101
-
Number of sells
-
64
Institutional Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q2 2016
As of 30 Jun 2016,
HAEMONETICS CORP - Common Stock (HAE) was held by
169 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,973,144 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BlackRock Fund Advisors, WELLS FARGO & COMPANY/MN, WELLINGTON MANAGEMENT GROUP LLP, FULLER & THALER ASSET MANAGEMENT, INC., Black Creek Investment Management Inc., Neuberger Berman Group LLC, DIMENSIONAL FUND ADVISORS LP, and Van Berkom & Associates Inc..
This page lists
169
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.